06-16-2021 / Learn about how vaccine or infection-induced T cell responses against the original SARS-CoV-2 strain remain protective against new variants.

04-12-2021 / Learn about a new approach to the treatment of Parkinson's disease alpha-synuclein pathology that uses a cell-penetrating peptide to induce proteasome degradation of alpha-synuclein.

01-18-2021 / Non-Coding Sequences Expand Neoantigens for Therapy

01-11-2021 / How the Proteasome Modulates the Immunopeptidome

01-03-2021 / α-Hemolysin derived from Staphylococcus aureus Promotes Inflammation Resolution through Generation of Specialized Pro-resolving Mediators

10-11-2020 / Peptide libraries allow investigators to identify epitopes inducing T cell activation which may be used in the design of vaccines to treat infectious diseases such as COVID.

09-22-2020 / Learn about how B and T cells respond to COVID, the elements defining an effective immune response to SARS-CoV-2 infection, and the epitopes driving these responses.

07-28-2020 / Precision medicine is tailoring patient treatment based on the genotype of a patients individual tumor associated antigens and tumor specific antigens (neoantigens).

09-24-2019 / Neoantigens, also known as tumor-specific antigens, is a class of HLA-bound peptides generated by tumor-specific mutations.